Assess the frequency and severity of adverse drug reactions due to errors in drug intake at a tertiary care hospital
Keywords:Errors, Adverse drug reactions, Self-medication
Background: Drug-related problems are an important cause of morbidity and mortality and a significant burden on healthcare resources. There are few studies to account for errors in drug intake leading to adverse drug reactions (ADRs). This study was pursued with the objective of determining the frequency and severity of the ADRs resulting from erroneous drug intake, the expenses incurred in treating the same.
Methods: The study was a prospective, cross-sectional, observational study. The study subjects were patients with ADRs due to errors in drug intake and from self-medication. All the information regarding the ADR were collected as per ADR reporting form issued by Central Drugs Standard Control Organization. Causality was assessed by both Naranjo and the WHO criteria for causality assessment. Direct cost of all the medications, hospital charges (admission, bed charges, consultations paid, treatment charges, investigations, and conveyance charges) were recorded to find the financial burden due to error in drug intake.
Results: The study showed that nearly 30% of the ADRs were due to errors in drug intake and the major contributing factor is self-modification either by discontinuation or missed doses. Major drugs that are implicated in these ADRs were that of metformin and insulins among anti-diabetic drugs and amlodipine and atenolol among antihypertensives. These two groups contributed to 18 (62%) of the total 29 ADRs. Organ system commonly involved was central nervous system and that was followed by musculoskeletal system. The average direct cost incurred in the management of these ADRs was Rs. 5773 for non-serious adverse events (SAE’s) and Rs. 11,400 for SAE’s.
Conclusion: Proper education about the importance of compliance and damaging consequences of self-modification of drug dosage in patients who are on treatment for chronic disorders like diabetes and hypertension will be an effective strategy to prevent many of these ADRs.
Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B, et al. Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf. 2007;30(1):81-8.
Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007;147(11):755-65.
Asseray N, Ballereau F, Trombert-Paviot B, Bouget J, Foucher N, Renaud B, et al. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments. Drug Saf. 2013;36(12):1159-68.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9.
ICH Harmonised Tripartite Guideline 2003. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf. Updated 03 November 2003.
Suspected Adverse Drug Reaction Reporting form New Delhi: Ministry of Health and Family Welfare, Government of India. Available at http://www.cdsco.nic.in/writereaddata/ADR%20form%20PvPI.pdf. Accessed 14 May 2015.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.
The use of the WHO–UMC system for standardized case causality assessment. Available at http://www.WHO-UMC.org/graphics/4409.pdf. Accessed 14 May 2015.
Current Index of Medical Specialties (CIMS). Bangalore: UBM Medica India Private Limited; 2014.
Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83-90.
Gururaj, Maheshwaran. Kuppuswamy’s socio-economic status scale - a revision of income parameter for 2014. Int J Recent Trends Sci Technol. 2014;11(1):1-2.
Shivaprakash G, Akash, Nishith RS, Basu A, Pallavi S, Adhikari P, et al. Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in southern India. Drug Invent Today. 2012;4(12):671-3.
Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm. 2003;60(3):253-9.
Prabhakaran D, Ajay V. Non-Communicable Disease in India: a Perspective. New Delhi, India: Centre for Chronic Disease Control Discussion Report for the WHO; 2009.